The diffusion of Performance and Image-Enhancing Drugs (PIEDs) on the Internet: The Abuse of the Cognitive Enhancer Piracetam
暂无分享,去创建一个
[1] J. McVeigh,et al. United Kingdom drug situation: annual report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2012. , 2013 .
[2] F. S. Bersani,et al. Drops of madness? Recreational misuse of tropicamide collyrium; early warning alerts from Russia and Italy. , 2013, General hospital psychiatry.
[3] Suzanne Fergus,et al. Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances in the EU: the outcomes of the ReDNet project , 2013, Human psychopharmacology.
[4] A. Marchi,et al. Analisi dei report online relativi al potenziale uso errato della benzidamina , 2013 .
[5] Cinzia Pezzolesi,et al. Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[6] O. Corazza,et al. Consideration of the novel psychoactive substances (‘legal highs’) , 2011 .
[7] Fabrizio Schifano,et al. Designer drugs on the internet: a phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly. , 2011, Current clinical pharmacology.
[8] Michele Piccione,et al. Is There a Recreational Misuse Potential for Pregabalin? Analysis of Anecdotal Online Reports in Comparison with Related Gabapentin and Clonazepam Data , 2011, Psychotherapy and Psychosomatics.
[9] R. Oswald,et al. Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. , 2010, Journal of medicinal chemistry.
[10] S. Rubinelli,et al. Cyberdrugs: a cross-sectional study of online pharmacies characteristics. , 2009, European journal of public health.
[11] Herman D. Tolentino,et al. Use of Unstructured Event-Based Reports for Global Infectious Disease Surveillance , 2009, Emerging infectious diseases.
[12] J. Baker,et al. Counterfeiting in performance- and image-enhancing drugs. , 2009, Drug testing and analysis.
[13] B. Larance,et al. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. , 2008, Drug and alcohol review.
[14] B. Winblad. Piracetam: a review of pharmacological properties and clinical uses. , 2006, CNS drug reviews.
[15] Fabrizio Schifano,et al. Drugs on the web; the Psychonaut 2002 EU project , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[16] Fabrizio Schifano,et al. Internet pharmacies and online prescription drug sales: a cross-sectional study , 2005 .
[17] Fabrizio Schifano,et al. Importance of Cyberspace for the Assessment of the Drug Abuse Market: Preliminary Results from the Psychonaut 2002 Project , 2003, Cyberpsychology, Behavior, and Social Networking.
[18] B. Winblad,et al. Clinical Efficacy of Piracetam in Cognitive Impairment: A Meta-Analysis , 2002, Dementia and Geriatric Cognitive Disorders.
[19] W. Müller,et al. Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain. , 1997, Biochemical pharmacology.
[20] D. Oliver,et al. Cerebral blood flow effects of piracetam, pentifylline, and nicotinic acid in the baboon model compared with the known effect of acetazolamide. , 1996, Arzneimittel-Forschung.
[21] V. N. Grafova,et al. [The action of piracetam and its complex with sodium oxybutyrate in the neuropathic pain syndrome]. , 1996, Экспериментальная и клиническая фармакология.
[22] J. P. Andrade,et al. Piracetam promotes mossy fiber synaptic reorganization in rats withdrawn from alcohol. , 1996, Alcohol.
[23] R. Brasseur,et al. Piracetam-induced changes to membrane physical properties. A combined approach by 31P nuclear magnetic resonance and conformational analysis. , 1995, Biochemical pharmacology.
[24] A. Cadete-Leite,et al. Piracetam impedes hippocampal neuronal loss during withdrawal after chronic alcohol intake. , 1995, Alcohol.
[25] Cohen Sa,et al. Effects of piracetam on N-methyl-D-aspartate receptor properties in the aged mouse brain. , 1993 .
[26] Jenny Knight,et al. Promoting innovation , 1988, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[27] D. Varonos,et al. Piracetam attenuates the changes in the surface potential of the phosphatidylcholine monolayer produced by alcohols. , 1985, Acta anaesthesiologica Belgica.
[28] O. Corazza,et al. [Analysis of online reports on the potential misuse of benzidamine]. , 2013, Rivista di psichiatria.
[29] Dear Mr,et al. Inspections, Compliance, Enforcement, and Criminal Investigations , 2012 .
[30] P. Wiles. Statement for publica tion of the APC and ACMD websites Review of the Animal Procedures Committee (APC) and Advisory Council on the Misuse of Drugs (ACMD) , 2010 .
[31] J. Ballenger. efficacy of Piracetam in the Treatment of Tardive Dyskinesia in Schizophrenic Patients : a Randomized, Double-blind, Placebo-controlled Crossover Study , 2009 .
[32] S. Cohen,et al. Effects of piracetam on N-methyl-D-aspartate receptor properties in the aged mouse brain. , 1993, Pharmacology.
[33] C. Giurgea. [Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology]. , 1972, Actualites pharmacologiques.